Skip to content

Oramed Pharmaceuticals Inc.

ORMP· NasdaqCore metricsCIK 1176309

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -2.30%
Market cap
$175.25M
43.49M shares
Filings
951
$2.00M
FY 2025+49.3% FY25 yoy
$18.41M
Q3 2026N/M FY25 yoy
-$4.10M
Q3 2026N/M FY25 yoy
-$2.70M
Q3 2026derivedN/M FY25 yoy
$0.43
Q3 2026N/M FY25 yoy
$28.93M
Q3 2026−15.6% FY25 yoy
$175.25M
2.7×
87.6×
0.5×
-5.22%
—

FY2025 figures · derived

Price

$4.03+68.62%+$1.64past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$2.00MFY 2025
$2.71M0FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$2,000,000reported
FY 20232023-12-31$1,340,000reported
FY 20222022-12-31$2,703,000reported
FY 20212021-08-31$2,703,000reported
FY 20202020-08-31$2,710,000reported
FY 20192019-08-31$2,703,000reported
FY 20182018-08-31$2,449,000reported
FY 20172017-08-31$2,456,000reported
FY 20162016-08-31$641,000reported

Capital returns

Dividends and buybacks · FY2024 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$4.74M$4.74M$0.2540.45M sh−1.0%—
FY2024—$2.48M$2.48M—40.85M sh+0.8%—

Pharmaceutical preparations

Oramed Pharmaceuticals Inc. is the 202nd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR